The organizers of AlgaEurope, happening virtually from December 7-10, have announced three new conference sponsors: Buggypower — Bronze Sponsor, Yemoja — Bronze Sponsor, and REBECA Project — Gold Sponsor.
Buggypower is a private biotech company dedicated to the design, construction and operation of microalgae production units. As microalgae life creators, Buggypowers’ mission is to capture and fix CO₂ using marine microalgae. This is done in proprietary, highly controlled, closed photobioreactors allowing better control of growth parameters, preventing evaporation and contamination, reducing CO₂ losses, and allowing higher volumetric productivities. In the process, maximum quality marine microalgae are produced, using only sustainable raw materials: water, nutrients, sunlight, and CO₂.
Buggypower is producing three species of microalgae for a wide range of applications, from cosmetics to nutraceuticals, with a special focus on feed and functional foods. Several products are already being commercialized worldwide through Buggypowers’ subsidiary company Bluevert Lab™.
Buggypower is a reference for the model that the EU is supporting as the way forward regarding the Blue and Circular Economies because of their sustainability, scalability and generation of high added-value products with significant impact on health and well being.
Marine ingredient start-up Yemoja, Ltd. was founded four years ago by a team of marine biology and biotech experts. They shared a vision of leveraging novel engineering methods to provide a prodigious range of high value microalgae species that can be tailored to a full spectrum of applications.
Their mission is to boost the entire microalgae value chain with new varieties and bring them to the mainstream of high-end nutraceutical food as well as cosmeceutical spheres. Additional formulations in the future should also bring a positive impact to the cultivated meat market with the help of algae-derived blood substitutes. Their patented technology evolved from a deep-rooted appreciation of biopharma and marine sciences, supported by extensive experience in algae cultivation. This capacity was collectively harnessed in order to produce a variety of pure algae at any scale in a short time.
The company has created a platform for cultivating custom-designed, pharmaceutical grade microalgae on demand that utilizes high-precision, fast-track photobioreactor technology. It can be tailored to the desired nutritional compounds and functionalities. They can produce algae-centered ingredients standardized to any bioactive compound or algae extract encompassing astaxanthins, polysaccharides, xanthophylls, carotenoids, enzymes and more.
Yemoja’s super-intensive cultivation methodology overcomes many of the industry’s hurdles, specifically compositional homogeneity, scalability, and contamination proofing to ensure clean and safe microalgae throughout the process.
These microalgae are a powerful source of natural, vegan, and bioactive ingredients. Their innovative approach serves to create pure and sustainable microalgae derived products of the highest quality using green technology that can be naturally adapted into any desired matrix.
The REBECA Project is a platform for promoting Blue Biotechnology within the Macaronesian region. REBECA brings together culture collections, R&D centers, and the government administration with the mission of conserving and enhancing biodiversity. It serves as an embryo for the development and implementation of an innovative industry based on the cultivation of microalgae and cyanobacteria. One of their partners is the Economic Development Agency of Gran Canaria, a local institution supporting the economic diversification, development, and expansion on the island. Also partnering is the Spanish Bank of Algae, an R&D infrastructure with capacities for the isolation, characterization, conservation, supply, and development of cultivation techniques and applications of microalgae and cyanobacteria.
Protein isolates from seaweed
Genesea, an Israeli start-up, is reducing reliance on terrestrial crops in favor of marine algae. Read More
Algae + salamanders = innovative drugs
This pair could lead to innovative drugs that regulate human immune systems and tissue repair. Read More
Saudi Arabia to promote algae industry
The first commercial model for the cultivation of algae will be established in 2022. Read More
Goa setting up seaweed farming pilot project
The state’s 100-km long coastline has 145 species of seaweed that all are edible. Read More
Six seaweeds worthy of farming in NZ
Karengo, Asparagopsis, and agarophytes are three. (Click for the other three.) Read More
All rights reserved. Permission required to reprint articles in their entirety. Must include copyright statement and live hyperlinks. Contact firstname.lastname@example.org. Algae Planet accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.